Location: Home > News Center > Company News > PerkinElmer Agrees to Acquire Antibody Innovator BioLegend

PerkinElmer Agrees to Acquire Antibody Innovator BioLegend
Source:SSI DateTime:2021-10-22 views

We are delighted to share that PerkinElmer is joining with leading antibody and reagent provider, BioLegend.



This combination, the largest in PerkinElmer history, will help build on our life science capabilities. We are looking forward to better enabling our customers to conduct legendary work at the forefront of scientific discovery, bringing novel therapeutics to market more quickly, productively and with higher success rates entering clinical trials.


Click here to learn more


Tag: